Targeting IRAK4 Signaling in PDAC: Turning the "Cold" Tumors to "Hot" Ones
- PMID: 35358509
- DOI: 10.1053/j.gastro.2022.03.036
Targeting IRAK4 Signaling in PDAC: Turning the "Cold" Tumors to "Hot" Ones
Comment on
-
IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma.Gastroenterology. 2022 Jun;162(7):2047-2062. doi: 10.1053/j.gastro.2022.02.035. Epub 2022 Mar 7. Gastroenterology. 2022. PMID: 35271824 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
